ArticleBMC medical research methodology2026
A comparative analysis of parametric, semiparametric and machine learning models for survival prediction.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurvival analysis is crucial in medical research. This study provides a comprehensive comparison of parametric, semi-parametric, and machine learning models for predicting disease-free survival (DFS) in colorectal cancer.
methodsUsing data from 2,088 patients in a Phase III trial (Project Data Sphere), we evaluated parametric models (Lognormal, Generalized Gamma), semi-parametric models (CoxPH and stratified Cox model) and machine learning models (Random Survival Forests, XGBoost). Performance was assessed using Area under the curve (AUC) and Brier score.
resultsAfter 10-fold cross-validation, the Random Survival Forest (RSF) model demonstrated superior discriminative performance (1-year AUC: 0.713, 5-year AUC: 0.799) and the best overall prediction accuracy (Brier score at 3 years: 0.148). Weighted Brier scores confirmed its robustness across clinical scenarios (equal weights: 0.144; FN weight=3: 0.179; FP weight=2: 0.205). Parametric and semi-parametric models showed stable intermediate performance (CV AUC: 0.68-0.70), while XGBoost exhibited severe overfitting with near-random CV AUC (0.49-0.57).
conclusionsEnsemble methods, particularly Random Survival Forest, provide superior predictive accuracy for Disease-free survival compared to traditional models. These advanced techniques offer significant potential for improving risk stratification and personalizing cancer care, though their integration requires addressing interpretability challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.